Replimune Group, Inc. (REPL) — Analyst outlook / Analyst consensus target is. Based on 15 analyst ratings, the consensus is bullish — 12 Buy, 3 Hold.
The consensus price target is $13.75 (low: $11.00, high: $18.00), representing an upside of 605.1% from the current price $1.95.
Analysts estimate Earnings Per Share (EPS) of $-2.83 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2025: actual $-3.07 vs est $-2.83 (missed -8.6%). Analyst accuracy: 92%.
REPL Stock — 12-Month Price Forecast
$13.75
▲ +605.13% Upside
Average Price Target
Based on 15 Wall Street analysts offering 12-month price targets for Replimune Group, Inc., the average price target is $13.75, with a high forecast of $18.00, and a low forecast of $11.00.
The average price target represents a +605.13% change from the last price of $1.95.
Highest Price Target
$18.00
Average Price Target
$13.75
Lowest Price Target
$11.00
REPL Analyst Ratings
Buy
Based on 15 analysts giving stock ratings to Replimune Group, Inc. in the past 3 months
EPS Estimates — REPL
92%
Analyst Accuracy
Accurate
1 year compared
Actual vs Estimate
2025
Actual –$3.07
vs Est –$2.83
▼ 7.9% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — REPL
Revenue Trend
Analysts expect stable revenue going forward.
